BRCA2 and neoplasm: To assess if c.1813dup and c.7796 A > G variants were in trans, multiplex ligation-dependent probe assay (MLPA) and Sanger sequencing of the BRCA2 gene were undertaken in normal tissue samples and tumor samples from FA663 (Table 1).